A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living with Obesity or Overweight with Weight-Related Comorbidities Who Do Not Have Diabetes
This research study is looking at a new medicine called KAI-9531 for adults who are overweight or have obesity and also have other health problems linked to their weight, but they do not have diabetes. The main goal is to find out if KAI-9531 helps people lose weight and keep it off when taken once a week. We also want to check if the medicine is safe and if it improves other health markers like waist size, blood pressure, and cholesterol levels. Participants will be involved for about 18 months, with some receiving KAI-9531 and others a dummy treatment (placebo) to fairly compare the effects.
At a glance
What is this study about?
This study is about exploring a new medication called KAI-9531. It's designed for people who are struggling with obesity or being overweight, especially if they have other health conditions that are related to their weight. It's important to know that this study is specifically for individuals who do not have diabetes.
The main aim of this research is to see how well KAI-9531 helps people lose weight over a period of about 18 months. We also want to understand if the weight loss achieved is significant and how many people reach certain weight loss goals, such as losing 5%, 10%, or even 25% of their body weight. Beyond just weight, we're interested in how KAI-9531 might affect other important health measures. This includes changes in waist size, blood pressure, and cholesterol levels, as these can also improve with weight management.
This is a 'Phase 3' study, which means the medicine has already been studied in smaller groups and shown some promise. Now, it's being tested in a larger group of people to confirm its effectiveness and safety before it could potentially be made available more widely. By participating, you would be helping researchers learn more about a potential new treatment option for obesity and related health issues.
Key takeaways
- This study is testing a new weight loss medicine for adults without diabetes.
- It aims to see if KAI-9531 helps people lose weight and is safe.
- You would take the medicine (or a placebo) once a week by injection for 18 months.
- Regular health checks, including blood tests and measurements, would be part of the study.
- Participation includes the chance of receiving the active drug or a placebo.
Who may be eligible?
To be considered for this study, you must be an adult, at least 18 years old or older. The study is open to both men and women.
A key requirement is that you are overweight or have obesity and also have some other health conditions linked to your weight. However, it's very important that you do not have diabetes to take part in this particular study.
Further checks will be made by the study team to ensure you meet all the specific criteria. This helps make sure the study gathers the most accurate and useful information.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you currently overweight or living with obesity?
- Do you have other health issues linked to your weight?
- Do you NOT have diabetes?
What does participation involve?
If you join this study, you would be involved for about 18 months. You would receive either the new medicine, KAI-9531, or a placebo (a dummy treatment that looks just like the real medicine but contains no active drug). Neither you nor your study doctor would know which you are receiving – this is to ensure fair results. The medicine would be given as an injection once a week.
Throughout the study, you would attend regular appointments at the study site. These visits would involve various assessments such as carefully weighing you, measuring your waist, checking your blood pressure, and taking blood samples to look at things like cholesterol and blood sugar levels. You might also be asked to complete questionnaires about your quality of life. All these checks help the study team understand how the medicine is working and monitor your health carefully. We would continue to monitor your health and any side effects during your time in the study.
Potential risks and benefits
Locations (6)
- —UnverifiedBulgaria
- —UnverifiedHungary
- —UnverifiedSpain
- —UnverifiedGermany
- —UnverifiedCzechia
- —UnverifiedPoland
Common questions
What is KAI-9531?
KAI-9531 is a new medicine being tested to see if it helps with weight loss in people who are overweight or have obesity.
Will I definitely lose weight if I join this study?
Not necessarily. Some people in the study will receive the active medicine, and others will receive a dummy treatment (placebo). There's no guarantee that the medicine will work for everyone, even if they receive it.
How often would I take the medicine?
If you're in the study, you would take the medicine as an injection once a week.
What does a 'placebo' mean?
A placebo is a dummy treatment that looks exactly like the actual medicine but doesn't contain any active drug. It helps researchers compare the effects of the real medicine fairly.
How long does the study last?
The study will involve you for about 18 months.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.